President Donald Trump is pushing ahead with announcements to TrumpRx.gov as Americans look for ways to cut the costs ...
Jayant Mishra said he was approved for a copay card covering $9,450 a year. He didn't realize how fast the money would run out.
Ayurveda is a comprehensive therapy as it aims at reducing inflammation, enhancing digestion, stabilizing the equilibrium ...
Amgen Inc. and GSK plc are reportedly set to announce their partnership with TrumpRx.gov. This collaboration is set to offer ...
Johnson & Johnson's much-anticipated oral IL-23 inhibitor, icotrokinra, has claimed FDA approval as a first-line treatment ...
New research suggests GLP-1 drugs may increase the risk of bone and tendon injuries and other conditions, including ...
GLP-1 receptor agonists like semaglutide are being used off-label by healthy people hoping to slow ageing, despite limited ...
President Donald Trump pledged to make prescription drugs cheaper for Americans than anywhere in the world, but his ...
Johnson & Johnson JNJ rapidly advanced its pipeline in 2025, attaining significant clinical and regulatory milestones that will help drive growth through the back half of the decade. In 2025, it ...
The number doctors use to demarcate hypertension keeps going down, a trend applauded by many experts, who point to studies ...
Diamond Hill Capital, an investment management company, released its “Mid Strategy” fourth-quarter 2025 investor letter. A ...
OUR resident specialist and NHS GP, Dr Zoe Williams, shares her expert advice. Today, Dr Zoe helps a reader who has recently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results